Pharma Financial Squeeze Bodes Ill for Genomics

Pharma Financial Squeeze Bodes Ill for Genomics
‘Caution: Tougher Times Ahead’ may be an apt sign for biotech in general and genomics in particular, according to a panel of leading venture capitalists.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!